The Company held an EGM this week with the purpose of authorizing
Magnus Østergaard Dahlmann (Board Member), comments:
- From the very beginning in 2018, it has been a great pleasure and a privilege for me to follow DanCann's start-up - and in recent years on the Board of Directors to help build the bridge to what is today
Per Wester (Board Member), comments:
- We have been on an absolutely amazing trip together and I wish to thank every one of you for allowing me to be a part of this journey. Jeppe, you are a great entrepreneur. In the years I have had the pleasure of working with you, you have developed insanely fast. Take good care of your new insights. I wish
- It has been a privilege to have Magnus and Per onboard on our growth journey. It is hard to believe how much we have achieved in just 3-4 years together and your contribution has been massive. I hope that you will continue to be the fantastic ambassadors - as you are - for
- At the same time, I am very happy to be able to welcome our two new board members.
Magnus Østergaard Dahlmann and Per Wester leave the Company as good leavers, and therefore retain their current warrants which are vested (25,000 warrants), and the remaining 50,000 warrants will withdrawal as these have not yet been vested.
About
Born in 1995. Founder and Chief Executive Officer (CEO) in
About
Born in 1983. Professional investor since 2016.
About
For more information, visit: www.dancann.com
For further information, please contact:
E-mail: jkr@dancann.com
Website: www.dancann.com
Disclaimer
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology.
Forward-looking statements are subject to several risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities.
Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this presentation are made as of the date of this presentation and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
https://news.cision.com/dancann-pharma/r/dancann-pharma-a-s-has-appointed-alexander-schoeneck-and-jeppe-krog-rasmussen-to-the-board-of-direct,c3634944
https://mb.cision.com/Main/19875/3634944/1629725.pdf
(c) 2022 Cision. All rights reserved., source